JUDITH WILLIAMS: Open Payments
NPI 1467115501 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,605 in 89 payments from 22 companies in 2025. Trend: 2023 $2,384 · 2024 $2,325 · 2025 $1,605
Food & beverage: $1,605
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $499 |
| Novo Nordisk Inc | 7 | $145 |
| Amgen Inc. | 5 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Exact Sciences Corporation | 4 | $79 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| IBSA Pharma Inc. | 4 | $74 |
| PFIZER INC. | 4 | $73 |
| Lilly USA, LLC | 4 | $71 |
| Dexcom, Inc. | 3 | $69 |
Products named: QULIPTA, Cologuard Collection Kit, Tirosint, Dexcom G6 Transmitter, UBRELVY, AIRSUPRA, Wegovy, Ozempic.
Industry payments across TX — which companies pay providers there.
